PerkinElmer announces acquisition of chemagen Biopolymer-Technologie

PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that it has acquired chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company's strategy to advance its offerings to the molecular diagnostics and research markets.

Daniel R. Marshak, PhD, chief scientific officer and president, Emerging Diagnostics, PerkinElmer, said, "The addition of chemagen's complementary products to PerkinElmer's portfolio will provide the Company with robust platforms and solutions to meet the needs of the rapidly evolving molecular diagnostics market. The hardware and reagent capabilities brought by chemagen include a total solution in nucleic acid sample preparation, with automation-enabling features that can power high throughput applications in research, screening, and diagnostics."

He added, "Nucleic acids are the building blocks of DNA and RNA, modulators of genetic function and information. Our ability to provide automated nucleic acid isolation technologies through this acquisition significantly facilitates applications such as large-scale pathogen detection in blood banking, human genetics applications such as HLA typing, autoimmune analysis and tissue rejection analysis. PerkinElmer has worked with chemagen for years to provide automated liquid-handling platforms with DNA preparation capabilities. chemagen is a natural fit with our business."

Source:

PerkinElmer, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PerkinElmer. (2019, June 19). PerkinElmer announces acquisition of chemagen Biopolymer-Technologie. News-Medical. Retrieved on August 23, 2019 from https://www.news-medical.net/news/20110214/PerkinElmer-announces-acquisition-of-chemagen-Biopolymer-Technologie.aspx.

  • MLA

    PerkinElmer. "PerkinElmer announces acquisition of chemagen Biopolymer-Technologie". News-Medical. 23 August 2019. <https://www.news-medical.net/news/20110214/PerkinElmer-announces-acquisition-of-chemagen-Biopolymer-Technologie.aspx>.

  • Chicago

    PerkinElmer. "PerkinElmer announces acquisition of chemagen Biopolymer-Technologie". News-Medical. https://www.news-medical.net/news/20110214/PerkinElmer-announces-acquisition-of-chemagen-Biopolymer-Technologie.aspx. (accessed August 23, 2019).

  • Harvard

    PerkinElmer. 2019. PerkinElmer announces acquisition of chemagen Biopolymer-Technologie. News-Medical, viewed 23 August 2019, https://www.news-medical.net/news/20110214/PerkinElmer-announces-acquisition-of-chemagen-Biopolymer-Technologie.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
New automated workstation for enhanced process development of protein therapeutics